4.8 (741) · $ 19.50 · In stock
The nature and cellular sources of NGAL, its biological role and diagnostic ability in AKI and the increasing concerns surrounding its diagnostic and clinical value are described. For many years, neutrophil gelatinase-associated lipocalin (NGAL) has been considered the most promising biomarker of acute kidney injury (AKI). Commercial assays and point-of-care instruments, now available in many hospitals, allow rapid NGAL measurements intended to guide the clinician in the management of patients with or at risk of AKI. However, these assays likely measure a mixture of different NGAL forms originating from different tissues. Systemic inflammation, commonly seen in critically ill patients, and several comorbidities contribute to the release of NGAL from haematopoietic and non-haematopoietic cells. The unpredictable release and complex nature of the molecule and the inability to specifically measure NGAL released by tubular cells have hampered its use a specific marker of AKI in heterogeneous critically ill populations. In this review, we describe the nature and cellular sources of NGAL, its biological role and diagnostic ability in AKI and the increasing concerns surrounding its diagnostic and clinical value.
Acute kidney injury in the critically ill: an updated review on
Role of biomarkers in the diagnosis and prognosis of acute kidney
Strategies to mitigate acute kidney injury risk during physical
Neutrophil Gelatinase-assoc Lipocalin (NGAL): promising biomarker
Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population, BMC Nephrology
Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients, Annals of Intensive Care
Full article: Renal Restrictive Index (RRI) Versus Urinary
Neutrophil gelatinase-associated lipocalin does not originate from
PDF) Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the
Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population, BMC Nephrology
Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients - Itir Yegenaga, Fatih Kamis, Canan Baydemir, Elizade Erdem, Koray
Acute kidney injury - The Lancet
Pathogens, Free Full-Text
Medicina, Free Full-Text